Clinical trial protocol: PRednisolone in early diffuse cutaneous Systemic Sclerosis (PRedSS):
2020
Background:Many of the painful, disabling features of early diffuse cutaneous systemic sclerosis have an inflammatory component and are potentially treatable with corticosteroid therapy. These feat...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
51
References
0
Citations
NaN
KQI